Table of Contents 1. Analyst View 2. Research Methodology 3. In Vitro Diagnostic Market Overview 3.1 Introduction 3.2 What is In Vitro Diagnostics? 3.3 Market Size and Growth 4. Point-of-Care Diagnostics Market Outlook 2020 5. Market Segmentation 5.1 By Application 5.2 By Geography 6. Market Drivers and Challenges 6.1 Drivers 6.2 Challenges 7. Industry Trends and Developments 7.1 Portable Ultrasound Providing Care on Site 7.2 Microfluidics Technology Crowding the POCT Industry 8. Competitive Landscape 8.1 Market Share of Major Players 8.2 Key Players 8.2.1 Roche Holding Ltd. 8.2.2 Abbott Laboratories 8.2.3 Johnson and Johnson 8.2.4 Alere 8.2.5 Medtronic 8.2.6 Bayer HealthCare 8.2.7 Siemens HealthCare 8.2.8 Beckman Coulter 8.2.9 Bio-Rad 8.2.10 Becton Dickinson 9. Future Outlook/Market Opportunities List of Figures
Figure 3-1: Global - Diabetes Incidence (Million), 2014 & 2035 Figure 3-2: Global - In Vitro Diagnostic Market (Billion US$), 2014-2020 Figure 3-3: Global - In Vitro Diagnostic Market by Region (%), 2014 Figure 3-4: Global - In Vitro Diagnostic Market by Region (%), 2020 Figure 3-5: Global - In Vitro Diagnostic Market by Players (%), 2014 Figure 4-1: Global - Share of POCT in the IVD Market (%), 2014 & 2020 Figure 4-2: Global - Point of Care Testing Market (Billion US$), 2014-2020 Figure 5-1: Global - Point of Care Testing Market by Application (%), 2014 Figure 5-2: Global - Point of Care Testing Market by Application (%), 2020 Figure 5-3: Global - Point of Care Testing Market by Players (%), 2014 Figure 8-1: Global - Point-of-Care Testing Market by Players (%), 2014 Figure 8-2: Roche Holdings Ltd - Revenue by Business Segment (%), 2014 Figure 8-3: Abbott Laboratories - Revenue by Business Segment (%), 2014 Figure 8-4: Abbott Laboratories - Revenue by Region (%), 2014 Figure 8-5: Johnson & Johnson - Revenue by Business Segment (%), 2014 Figure 8-6: Johnson & Johnson - Medical Devices and Dx Revenue by Segment (%), 2014 Figure 8-7: Johnson & Johnson - Revenue by Region (%), 2014 Figure 8-8: Johnson & Johnson - Medical Devices and Dx Revenue by Region (%), 2014 Figure 8-9: Alere Inc. - Revenue by Business Segment (%), 2013 Figure 8-10: Alere Inc. - Professional Diagnostic Division Revenue by Segment (%), 2013 Figure 8-11: Medtronic Inc. - Revenue by Business Segment (%), 2014 Figure 8-12: Medtronic Inc. - Revenue by Region (%), 2014 Figure 8-13: Bayer HealthCare - Revenue by Business Segment (%), 2014 Figure 8-14: Bayer HealthCare - Revenue by Business Region (%), 2014 Figure 8-15: Bayer HealthCare - Consumer Health Revenue by Segment (%), 2014 Figure 8-16: Siemens HealthCare - Revenue by Region (%), 2014 Figure 8-17: Siemens HealthCare - Revenue by Business Segment (%), 2014 Figure 8-18: Bio-Rad - Revenue by Segment (%), 2014 Figure 8-19: Bio-Rad - Revenue by Region (%), 2014 Figure 8-20: Becton Dickinson - Revenue by Business Segment (%), 2014 Figure 8-21: Becton Dickinson - Revenue by Region (%), 2014 List of Tables
Table 8-1: Roche Holdings Ltd - POCT Product Portfolio Table 8-2: Roche Holdings Ltd - Key POCT Product Launches for 2015 Table 8-3: Roche Holdings Ltd - Key Financials (Million CHF), 2012-2014 Table 8-4: Roche Holdings Ltd - Strengths and Weaknesses Table 8-5: Abbott Laboratories - POCT Product Portfolio Table 8-6: Abbott Laboratories - Key Financials (Million US$), 2012-2014 Table 8-7: Abbott Laboratories - Strengths and Weaknesses Table 8-8: Johnson & Johnson - POCT Product Portfolio Table 8-9: Johnson & Johnson - Key Financials (Million US$), 2012-2014 Table 8-10: Johnson & Johnson - Strengths and Weaknesses Table 8-11: Alere Inc. - POCT Product Portfolio Table 8-12: Alere Inc. - Key Financials (Million US$), 2011-2013 Table 8-13: Alere Inc. - Strengths and Weaknesses Table 8-14: Medtronic Inc. - POCT Product Portfolio Table 8-15: Medtronic Inc. - Key Financials (Million US$), 2012-2014 Table 8-16: Medtronic Inc. - Strengths and Weaknesses Table 8-17: Bayer HealthCare - POCT Product Portfolio Table 8-18: Bayer HealthCare - Key Financials (Million ¢æ), 2012-2014 Table 8-19: Bayer HealthCare - Strengths and Weaknesses Table 8-20: Siemens Healthcare - POCT Product Portfolio Table 8-21: Siemens Healthcare - Key Financials (Million ¢æ), 2012-2014 Table 8-22: Siemens Healthcare - Strength and Weaknesses Table 8-23: Beckman Coulter - POCT Product Portfolio Table 8-24: Beckman Coulter - Strengths and Weaknesses Table 8-25: Bio-Rad - POCT Product Portfolio Table 8-26: Bio-Rad - Key Financials (Million US$) 2012-2014 Table 8-27: Bio-Rad - Strengths and Weaknesses Table 8-28: Becton Dickinson - POCT Product Portfolio Table 8-29: Becton Dickinson - Key Financials (Million US$), 2012-2014 Table 8-30: Becton Dickinson - Strengths and Weaknesses
|